Evidence map›Paper›PMID 35536377›Full record

ArticleHuman genetics2022

Transmission ratio distortion of mutations in the master regulator of centriole biogenesis PLK4.

Heidemarie Neitzel, Raymonda Varon, Sana Chughtai, Josephine Dartsch, Véronique Dutrannoy-Tönsing, Peter Nürnberg, Gudrun Nürnberg, Michal Schweiger, Martin Digweed, Gabriele Hildebrand and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. The fan base for embryo selection strategies: enlightened or flummoxed.Journal of assisted reproduction and genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Heidemarie NeitzelInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Raymonda VaronInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sana ChughtaiInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Josephine DartschInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Véronique Dutrannoy-TönsingInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Peter NürnbergCologne Center for Genomics, University of Cologne, University Hospital Cologne, Cologne, Germany.
Gudrun NürnbergCologne Center for Genomics, University of Cologne, University Hospital Cologne, Cologne, Germany.
Michal SchweigerCenter for Molecular Medicine Cologne, Laboratory for Epigenetics and Tumour Genetics, University of Cologne, Cologne, Germany.
Martin DigweedInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gabriele HildebrandInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Karl HackmannInstitut Fuer Klinische Genetik, Medizinische Fakultaet Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany.
Manuel HoltgreweBerlin Institute of Health (BIH), Core Unit Bioinformatics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Nanette SariogluInstitute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bernt SchulzeThe Genetics Clinic, Hannover, Germany.
Denise HornInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Karl SperlingInstitute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany. karl.sperling@charite.de.ORCID http://orcid.org/0000-0003-2305-4370
Charité - Universitätsmedizin Berlin · DEUniversity of Cologne · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEUniversity Hospital Carl Gustav Carus · DE

Funding

Deutsche Forschungsgemeinschaft Collaborative Research Center 1399Deutsche Forschungsgemeinschaft Collaboratve Research Center 577Deutsche Forschungsgemeinschaft NE 531/5-1Higher Education Commision, Pakistan A/04/30796
6 · The paper itself

Abstract

The evolutionary conserved Polo-like kinase 4 (PLK4) is essential for centriole duplication, spindle assembly, and de novo centriole formation. In man, homozygous mutations in PLK4 lead to primary microcephaly, altered PLK4 expression is associated with aneuploidy in human embryos. Here, we report on a consanguineous four-generation family with 8 affected individuals compound heterozygous for a novel missense variant, c.881 T > G, and a deletion of the PLK4 gene. The clinical phenotype of the adult patients is mild compared to individuals with previously described PLK4 mutations. One individual was homozygous for the variant c.881G and phenotypically unaffected. The deletion was inherited by 14 of 16 offspring and thus exhibits transmission ratio distortion (TRD). Moreover, based on the already published families with PLK4 mutations, it could be shown that due to the preferential transmission of the mutant alleles, the number of affected offspring is significantly increased. It is assumed that reduced expression of PLK4 decreases the intrinsically high error rate of the first cell divisions after fertilization, increases the number of viable embryos and thus leads to preferential transmission of the deleted/mutated alleles.

Indexed as

Cell Cycle ProteinsCentriolesCell DivisionHumansMutationProtein Serine-Threonine KinasesCell Cycle ProteinsPLK4 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID35536377
PMCPMC9556372
OpenAlexW4229439217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.